Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (8): 759-763.DOI: 10.3969/j.issn.1673-8640.2024.08.007
Previous Articles Next Articles
HUANG Linling, XU Meirong(), SHEN Xiaowen, GU LingLi, SHEN Hongmei
Received:
2023-06-05
Revised:
2023-11-20
Online:
2024-08-30
Published:
2024-09-02
CLC Number:
HUANG Linling, XU Meirong, SHEN Xiaowen, GU LingLi, SHEN Hongmei. Changes and significance of autophagy in peripheral blood lymphocytes of patients with carbapenem-resistant Enterobacteriaceae-bloodstream infection[J]. Laboratory Medicine, 2024, 39(8): 759-763.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.08.007
组别 | 例数 | Beclin-1 mRNA | LC3 mRNA | Atg5a mRNA |
---|---|---|---|---|
耐药组 | 125 | 0.58±0.07*# | 0.51±0.05*# | 0.71±0.09*# |
敏感组 | 130 | 0.74±0.10* | 0.81±0.11* | 0.83±0.12* |
对照组 | 105 | 1.00±0.15 | 1.00±0.19 | 1.00±0.18 |
F值 | 34.835 | 57.115 | 45.345 | |
P值 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | Beclin-1 mRNA | LC3 mRNA | Atg5a mRNA |
---|---|---|---|---|
耐药组 | 125 | 0.58±0.07*# | 0.51±0.05*# | 0.71±0.09*# |
敏感组 | 130 | 0.74±0.10* | 0.81±0.11* | 0.83±0.12* |
对照组 | 105 | 1.00±0.15 | 1.00±0.19 | 1.00±0.18 |
F值 | 34.835 | 57.115 | 45.345 | |
P值 | <0.001 | <0.001 | <0.001 |
指标 | Beclin-1 mRNA | LC3 mRNA | Atg5a mRNA | |||||
---|---|---|---|---|---|---|---|---|
r值 | P值 | r值 | P值 | r值 | P值 | |||
APACHE Ⅱ评分 | -0.341 | 0.018 | -0.401 | <0.05 | -0.355 | 0.015 | ||
WBC | -0.362 | 0.015 | -0.357 | <0.05 | -0.421 | 0.005 | ||
hs-CRP | -0.294 | 0.025 | -0.324 | <0.05 | -0.392 | 0.009 | ||
PCT | -0.344 | 0.018 | -0.409 | <0.05 | -0.385 | 0.009 |
指标 | Beclin-1 mRNA | LC3 mRNA | Atg5a mRNA | |||||
---|---|---|---|---|---|---|---|---|
r值 | P值 | r值 | P值 | r值 | P值 | |||
APACHE Ⅱ评分 | -0.341 | 0.018 | -0.401 | <0.05 | -0.355 | 0.015 | ||
WBC | -0.362 | 0.015 | -0.357 | <0.05 | -0.421 | 0.005 | ||
hs-CRP | -0.294 | 0.025 | -0.324 | <0.05 | -0.392 | 0.009 | ||
PCT | -0.344 | 0.018 | -0.409 | <0.05 | -0.385 | 0.009 |
项目 | 例数 | Beclin-1 mRNA | LC3 mRNA | Atg5a mRNA |
---|---|---|---|---|
死亡患者 | 93 | 0.40±0.07 | 0.38±0.05 | 0.60±0.08 |
存活患者 | 32 | 0.64±0.08 | 0.55±0.06 | 0.75±0.11 |
t值 | 15.091 | 14.390 | 7.088 | |
P值 | <0.001 | <0.001 | <0.001 |
项目 | 例数 | Beclin-1 mRNA | LC3 mRNA | Atg5a mRNA |
---|---|---|---|---|
死亡患者 | 93 | 0.40±0.07 | 0.38±0.05 | 0.60±0.08 |
存活患者 | 32 | 0.64±0.08 | 0.55±0.06 | 0.75±0.11 |
t值 | 15.091 | 14.390 | 7.088 | |
P值 | <0.001 | <0.001 | <0.001 |
项目 | 例数 | 性别 | 年龄/岁 | 合并症 | |||||
---|---|---|---|---|---|---|---|---|---|
男/例 | 女/例 | 高血压/ [例(%)] | 冠心病/ [例(%)] | 糖尿病/ [例(%)] | 慢性肺疾病/ [例(%)] | 慢性肾脏病/ [例(%)] | |||
死亡患者 | 32 | 17 | 15 | 56.01±9.93 | 10(31.25) | 3(9.38) | 4(12.50) | 9(28.13) | 2(6.25) |
存活患者 | 93 | 55 | 38 | 49.71±8.75 | 25(26.88) | 13(13.98) | 12(12.90) | 21(22.58) | 9(9.68) |
统计值 | 0.353 | 3.392 | 0.225 | 0.452 | 0.003 | 0.401 | 0.348 | ||
P值 | 0.553 | 0.001 | 0.635 | 0.501 | 0.953 | 0.526 | 0.555 | ||
项目 | 感染源 | 感染性休克/ [例(%)] | WBC/(×109·L-1) | ||||||
呼吸道来源/ [例(%)] | 腹腔来源/ [例(%)] | 泌尿系来源/ [例(%)] | 中心静脉导管/[例(%)] | 皮肤软 组织/ [例(%)] | 原发性菌 血症/ [例(%)] | ||||
死亡患者 | 13(40.63) | 5(15.63) | 4(12.50) | 4(12.50) | 2(6.25) | 4(12.50) | 14(43.75) | 12.41(8.32~16.51) | |
存活患者 | 20(21.51) | 25(26.88) | 11(11.83) | 17(18.28) | 8(8.60) | 12(12.90) | 19(20.43) | 11.67(7.89~15.67) | |
统计值 | 4.479 | 1.654 | 0.010 | 0.569 | 0.179 | 0.003 | 6.663 | 1.585 | |
P值 | 0.034 | 0.198 | 0.920 | 0.451 | 0.672 | 0.953 | 0.010 | 0.187 | |
项目 | Hb/ (g·L-1) | PLT计数/ (×109·L-1) | Alb/ (g·L-1) | hs-CRP/ (mg·L-1) | PCT/ (ng·mL-1) | APACHE Ⅱ评分/分 | |||
死亡患者 | 120.13±19.38 | 146.51±25.42 | 33.58±6.51 | 132.41(56.51~175.14) | 1.32(0.25~2.85) | 20.31±4.41 | |||
存活患者 | 125.57±20.35 | 152.31±27.51 | 34.12±4.59 | 85.51(31.32~134.41) | 0.83(0.14~1.37) | 15.68±3.48 | |||
统计值 | 1.320 | 1.048 | 0.512 | 8.498 | 9.741 | 6.046 | |||
P值 | 0.189 | 0.297 | 0.609 | <0.001 | <0.001 | <0.001 |
项目 | 例数 | 性别 | 年龄/岁 | 合并症 | |||||
---|---|---|---|---|---|---|---|---|---|
男/例 | 女/例 | 高血压/ [例(%)] | 冠心病/ [例(%)] | 糖尿病/ [例(%)] | 慢性肺疾病/ [例(%)] | 慢性肾脏病/ [例(%)] | |||
死亡患者 | 32 | 17 | 15 | 56.01±9.93 | 10(31.25) | 3(9.38) | 4(12.50) | 9(28.13) | 2(6.25) |
存活患者 | 93 | 55 | 38 | 49.71±8.75 | 25(26.88) | 13(13.98) | 12(12.90) | 21(22.58) | 9(9.68) |
统计值 | 0.353 | 3.392 | 0.225 | 0.452 | 0.003 | 0.401 | 0.348 | ||
P值 | 0.553 | 0.001 | 0.635 | 0.501 | 0.953 | 0.526 | 0.555 | ||
项目 | 感染源 | 感染性休克/ [例(%)] | WBC/(×109·L-1) | ||||||
呼吸道来源/ [例(%)] | 腹腔来源/ [例(%)] | 泌尿系来源/ [例(%)] | 中心静脉导管/[例(%)] | 皮肤软 组织/ [例(%)] | 原发性菌 血症/ [例(%)] | ||||
死亡患者 | 13(40.63) | 5(15.63) | 4(12.50) | 4(12.50) | 2(6.25) | 4(12.50) | 14(43.75) | 12.41(8.32~16.51) | |
存活患者 | 20(21.51) | 25(26.88) | 11(11.83) | 17(18.28) | 8(8.60) | 12(12.90) | 19(20.43) | 11.67(7.89~15.67) | |
统计值 | 4.479 | 1.654 | 0.010 | 0.569 | 0.179 | 0.003 | 6.663 | 1.585 | |
P值 | 0.034 | 0.198 | 0.920 | 0.451 | 0.672 | 0.953 | 0.010 | 0.187 | |
项目 | Hb/ (g·L-1) | PLT计数/ (×109·L-1) | Alb/ (g·L-1) | hs-CRP/ (mg·L-1) | PCT/ (ng·mL-1) | APACHE Ⅱ评分/分 | |||
死亡患者 | 120.13±19.38 | 146.51±25.42 | 33.58±6.51 | 132.41(56.51~175.14) | 1.32(0.25~2.85) | 20.31±4.41 | |||
存活患者 | 125.57±20.35 | 152.31±27.51 | 34.12±4.59 | 85.51(31.32~134.41) | 0.83(0.14~1.37) | 15.68±3.48 | |||
统计值 | 1.320 | 1.048 | 0.512 | 8.498 | 9.741 | 6.046 | |||
P值 | 0.189 | 0.297 | 0.609 | <0.001 | <0.001 | <0.001 |
自变量 | B值 | Wald值 | P值 | OR①值(95%CI②) |
---|---|---|---|---|
呼吸道来源感染 | 1.131 | 5.865 | <0.05 | 3.099(2.312-13.851) |
合并感染性休克 | 1.321 | 7.589 | <0.05 | 3.747(3.323-4.859) |
APACHE Ⅱ评分 | 0.103 | 11.385 | <0.05 | 1.108(1.052-1.323) |
Beclin-1 | -0.861 | 9.192 | <0.05 | 0.423(0.331-0.571) |
LC3 | -0.773 | 7.684 | <0.05 | 0.462(0.409-0.514) |
自变量 | B值 | Wald值 | P值 | OR①值(95%CI②) |
---|---|---|---|---|
呼吸道来源感染 | 1.131 | 5.865 | <0.05 | 3.099(2.312-13.851) |
合并感染性休克 | 1.321 | 7.589 | <0.05 | 3.747(3.323-4.859) |
APACHE Ⅱ评分 | 0.103 | 11.385 | <0.05 | 1.108(1.052-1.323) |
Beclin-1 | -0.861 | 9.192 | <0.05 | 0.423(0.331-0.571) |
LC3 | -0.773 | 7.684 | <0.05 | 0.462(0.409-0.514) |
[1] | SHRESTHA R, LUTERBACH C L, DAI W, et al. Characteristics of community-acquired carbapenem-resistant Enterobacterales[J]. J Antimicrob Chemother, 2022, 77(10):2763-2771. |
[2] | COPPOLA N, MARAOLO A E, ONORATO L, et al. Epidemiology,mechanisms of resistance and treatment algorithm for infections due to carbapenem-resistant gram-negative bacteria:an expert panel opinion[J]. Antibiotics(Basel), 2022, 11(9):1263. |
[3] |
THIESSEN S E, DERESE I, DERDE S, et al. The role of autophagy in critical illness-induced liver damage[J]. Sci Rep, 2017, 7(1):14150.
DOI PMID |
[4] |
HUANG S, XU M, LIU L, et al. Autophagy is involved in the protective effect of p21 on LPS-induced cardiac dysfunction[J]. Cell Death Dis, 2020, 11(7):554.
DOI PMID |
[5] | 刘成, 许雅倩, 邹琪. 脓毒症患者外周血淋巴细胞自噬相关基因Beclin-1和LC3的变化研究[J]. 中华全科医学, 2020, 18(6):913-916. |
[6] | 王佳, 高恒波, 林雪容, 等. 外周血Beclin-1、Atg5表达与老年脓毒症患者预后的相关性[J]. 重庆医学, 2022, 51(6):949-953. |
[7] | 代强, 郑波. 2012 美国疾病预防控制中心耐碳青霉烯类肠杆菌控制指南简介[J]. 中国医学前沿杂志(电子版), 2013(8):30-31. |
[8] | BUCHAN B W. Commentary:can automated blood culture systems be both new and improved?[J]. J Clin Microbiol, 2022, 60(4):e0019222. |
[9] | PERI A M, BAUER M J, BERGH H, et al. Performance of the BioFire blood culture identification 2 panel for the diagnosis of bloodstream infections[J]. Heliyon, 2022, 8(7):e09983. |
[10] | 何家花, 余成强, 李步荣. 血流感染病原学分析及与相关炎性因子的应用价值研究[J]. 现代检验医学杂志, 2020, 35(4):139-142. |
[11] |
顾凯, 李佳婕, 唐玉林. 住院患者碳青霉烯类耐药肠杆菌科细菌血流感染的发生及临床结局的影响因素评价:一项2017—2020年的回顾性研究[J]. 中国医院药学杂志, 2022, 42(9):902-907.
DOI |
[12] | 吴健锋. 脓毒症免疫抑制的监测和治疗进展[J]. 中山大学学报(医学科学版), 2020, 41(1):30-36. |
[13] | LUO R, LI X, WANG D. Reprogramming macrophage metabolism and its effect on NLRP3 inflammasome activation in sepsis[J]. Front Mol Biosci, 2022, 9:917818. |
[14] | WANG H, BAI G, CUI N, et al. T-cell-specific mTOR deletion in mice ameliorated CD4+ T-cell survival in lethal sepsis induced by severe invasive candidiasis[J]. Virulence, 2019, 10(1):892-901. |
[15] | YING L, ZHAO G J, WU Y, et al. Mitofusin 2 promotes apoptosis of CD4+ T cells by inhibiting autophagy in sepsis[J]. Mediators Inflamm, 2017, 2017:4926205. |
[16] | HUANG H, CUI Y, TIAN Z, et al. Tumor necrosis factor-α-induced protein 8-like 2 downregulation reduces CD4+ T lymphocyte apoptosis in mice with thermal injury[J]. Med Sci Monit, 2019, 25:7547-7556. |
[17] | ZHANG H, XU C F, REN C, et al. Novel role of p53 in septic immunosuppression:involvement in loss and dysfunction of CD4+ T lymphocytes[J]. Cell Physiol Biochem, 2018, 51(1):452-469. |
[18] |
尹章勇, 周华, 符一骐, 等. 耐碳青霉烯类肺炎克雷伯菌血流感染的临床特征和死亡危险因素分析[J]. 中国感染与化疗杂志, 2020, 20(4):388-395.
DOI |
[19] | DUAN X, ZHANG R, ZHANG X, et al. Identification of prognostic factors in patients with Streptococcus bloodstream infection[J]. Front Med(Lausanne), 2022, 9:832007. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||